# Safety and Efficacy Study on AFA-281 for the Treatment of Low Back Pain

> **NCT06649747** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Afasci Inc** · enrollment: 408 (estimated)

## Conditions studied

- Lumbosacral Radiculopathy

## Interventions

- **DRUG:** AFA-281

## Key facts

- **NCT ID:** NCT06649747
- **Lead sponsor:** Afasci Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-04-01
- **Primary completion:** 2032-03-31
- **Final completion:** 2032-03-31
- **Target enrollment:** 408 (ESTIMATED)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06649747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06649747, "Safety and Efficacy Study on AFA-281 for the Treatment of Low Back Pain". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06649747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*